Resource Centre
)
Using nanopore sequencing for mRNA vaccine quality control: a journey from R&D to GMP
- Biopharma
- Bioinformatics
- GridION
- Transcriptomics
September 18 2024
)
The potential of therapeutic mRNA — and how to measure it
- Biopharma
- Cancer research
- Clinical research
- MinION
- GridION
- Q-Line
September 18 2024
)
The art of GMP in the world of NGS: trials, tribulations, and a whole lot of acronyms — a success story
- Biopharma
- Clinical research
- Bioinformatics
- Human genomics
- GridION
- Structural variation
September 18 2024
)
Precision cell engineering enabled through nanopore sequencing
- Biopharma
- Bioinformatics
- P2
- Assembly
- Epigenetics
- Gene expression
September 18 2024
)
NESSI-Seq: novel cfDNA methylation assays for biomarker discovery and precision medicine
- Biopharma
- Cancer research
- Bioinformatics
- Human genomics
- PromethION
- Epigenetics
September 18 2024
)
Nanopore sequencing and functional screening of AAV genomes for optimal production and function
- Biopharma
- Clinical research
- Bioinformatics
- MinION
- Single cell
- Structural variation
September 18 2024
)
Implementation of sequencing in a regulated environment
- Biopharma
- Infectious disease
- Microbiology
- MinION
- GridION
- P2
September 18 2024
)
From plasmids to mRNA, comprehensive nanopore QC tests for biomanufacturing
- Biopharma
- GridION
- Assembly
- Gene expression
- Structural variation
- Transcriptomics
September 18 2024
)
Application of nanopore long-read sequencing to sterility testing for cell therapy products
- Bioinformatics
- Education
September 18 2024
)
Antibody discovery through post-vaccination single-cell transcriptomics and haplotype-resolved germline sequencing
- Biopharma
- Clinical research
- Bioinformatics
- Human genomics
- Infectious disease
- P2
September 18 2024
)
Adventitious agent screening by long-read NGS
- Biopharma
- Microbiology
- GridION
- Metagenomics
September 18 2024
)
A sensitive sample preparation pipeline for adventitious virus detection using nanopore sequencing
- Biopharma
- Bioinformatics
- GridION
- Metagenomics
- Targeted
September 18 2024
)
Use of Oxford Nanopore sequencing to evaluate potential transmission of hospital infections
- Infectious disease
- Microbiology
- MinION
- Whole genome
September 17 2024
)
Update from the Oxford Nanopore Technologies Applications team
September 17 2024
)
Unraveling gene expression patterns in pediatric germ cell tumors: a nanopore sequencing approach
- Cancer research
- Bioinformatics
- MinION
- Gene expression
- Transcriptomics
September 17 2024
)
Understanding the binding of multiple transcription factors by base-pair-resolution chromatin accessibility
- Clinical research
- Bioinformatics
- Human genomics
- MinION
- Chromatin conformation
- Epigenetics
September 17 2024
)
Ultra-rich human data — variant analysis with EPI2ME
- Bioinformatics
- Human genomics
- Population genomics
- EPI2ME
- Epigenetics
- SNVs
September 17 2024
)
Transforming cancer care: redefining cancer characterization and predisposition insights through nanopore sequencing
- Cancer research
- Human genomics
- MinION
- Flongle
- Epigenetics
- SNVs
September 17 2024
)
Studying disease-causing polymorphic transposable element insertions using nanopore sequencing
- Human genomics
- Epigenetics
- Gene expression
- Targeted
- Whole genome
September 17 2024
)
Smarter genomics for streamlined answers — ElysION, sample-to-answer nanopore sequencing device
- Biopharma
- Infectious disease
- Microbiology
- TurBOT
- Metagenomics
September 17 2024